Sort   by:  
 Page size 
TranscriptomicsMicroarray analysis of cross-talks between Jasmonate acid and ethylene signaling in Arabidopsis seedlings
Jasmonate and ethylene are two important plant hormones contributing plant resistance to biotic stresses synergistically. Our experimental results showed that two ethylene activated transcription factors (EIN3/EIL1) integrated both jasmonate and ethylene signaling in multiple developmental and defen...
ORGANISM(S): Arabidopsis 
2010-05-28 | E-GEOD-21762 | biostudies-arrayexpress
UnknownIdentification of biomarkers associated with synovitis in rheumatoid arthritis by bioinformatics analyses.
Not available
S-EPMC7502692 | biostudies-literature
UnknownIncidence and missed diagnosis risk of occult posterior malleolar fractures associated with the tibial shaft fractures: a systematic review.
Not available
S-EPMC8167951 | biostudies-literature
UnknownCommon clinical features of unilateral retinal pigment epithelium dysgenesis and combined hamartoma of the retina and retinal pigment epithelium.
Not available
S-EPMC8760665 | biostudies-literature
UnknownIntegration of Gene Expression Profile Data to Verify Hub Genes of Patients with Stanford A Aortic Dissection.
Not available
S-EPMC6662449 | biostudies-literature
UnknownIntegration of Gene Expression Profile Data of Human Epicardial Adipose Tissue from Coronary Artery Disease to Verification of Hub Genes and Pathways.
Not available
S-EPMC6900948 | biostudies-literature
UnknownCohort profile: The National Colorectal Cancer Cohort (NCRCC) study in China.
Not available
S-EPMC8672005 | biostudies-literature
UnknownBorosilicate bioactive glass synergizing low-dose antibiotic loaded implants to combat bacteria through ATP disruption and oxidative stress to sequentially achieve osseointegration.
Not available
S-EPMC11535878 | biostudies-literature
ProteomicsMolecular Glue Degraders of the RNA Binding Protein HuR to Treat BRAF-Mutant Colorectal Cancer
BRAF gain-of-function mutations, particularly BRAF(V600E), affect roughly 10% of all colorectal cancer (CRC) patients, and portend poor prognosis with limited therapeutic interventions. BRAF inhibitors such as Encorafenib are ineffective due to MAP kinase pathway reactivation driven by BRAF dimeriza...
ORGANISM(S): Homo Sapiens 
2025-12-21 | PXD072281 |
ProteomicsMolecular Glue Degraders of HuR to Treat BRAF-Mutant Colorectal Cancer
BRAF gain-of-function mutations, particularly BRAF(V600E), affect roughly 10% of all colorectal cancer (CRC) patients, and portend poor prognosis with limited therapeutic interventions. BRAF inhibitors such as Encorafenib are ineffective due to MAP kinase pathway reactivation driven by BRAF dimeriza...
ORGANISM(S): Homo Sapiens 
2026-04-19 | PXD077365 |
Sort   by:  
 Page size